This site is for healthcare professionals.
mibc-home-banner-upd
mibc-home-banner-upd-mob

For patients with muscle-invasive bladder cancer (MIBC), radical cystectomy provides a 5-year survival in ~50% of patients.1

There’s a need to optimise disease management to help improve these outcomes.2,3

aggressive-disease

What makes MIBC an aggressive disease?

current-treatment-options-and-limitations

What are the current treatment options and considerations for MIBC?

collaborative-approach-essential

Why is a collaborative approach essential in the treatment of MIBC?

References: 1. Witjes JA, Bruins HM, Carrión A, et al. EAU Guidelines on muscle-invasive and metastatic bladder cancer. Published March 2025. Accessed 26 September 2025. https://uroweb.org/guidelines/muscle-invasive-and-metastatic-bladder-cancer. 2. Dyrskjøt L, Hansel D, Efstanthiou J, et al. Bladder cancer. Nat Rev Dise Primers 2023;9(58):58. 3. Esteban-Villarrubia J, Torres-Jiménez J, Bueno-Bravo C, Subiela JD, Gajate P. Current and future landscape of perioperative treatment for muscle-invasive bladder cancer. Cancers 2023;15(3):566.